This Article Abstract Full Text (PDF) Data Supplement All Versions of this Article: 25/1/168    most recent 01.ATV.0000149145.00865.d9v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhao, Z. Articles by van der Westhuyzen, D. R. Search for Related Content PubMed PubMed Citation Articles by Zhao, Z. Articles by van der Westhuyzen, D. R.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:168.)
© 2005 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

Low-Density Lipoprotein From Apolipoprotein E-Deficient Mice Induces Macrophage Lipid Accumulation in a CD36 and Scavenger Receptor Class A-Dependent Manner

Zhenze Zhao; Maria C. de Beer; Lei Cai; Reto Asmis; Frederick C. de Beer; Willem J.S. de Villiers; Deneys R. van der Westhuyzen

From the Department of Internal Medicine and Graduate Center for Nutritional Sciences (Z.Z., M.C.d.B., L.C., R.A., F.C.d.B., W.J.S.d.V., D.R.v.d.W.), University of Kentucky Medical Center, Lexington; and Department of Veterans Affairs Medical Center (Z.Z., M.C.d.B., L.C., F.C.d.B., W.J.S.d.V., D.R.v.d.W.), Lexington, Ky.

Correspondence to D.R. van der Westhuyzen, PhD, Department of Internal Medicine and Graduate Center for Nutritional Sciences, Wethington Health Sciences Building 541, 900 S Limestone St, Lexington, KY 40536. E-mail dvwest1{at}uky.edu

	Abstract

Top Abstract Introduction Methods Results Discussion References

 
Objective— To investigate the potential of circulating low-density lipoprotein (LDL), isolated from apolipoprotein E (apoE)-deficient mice (E–/–LDL) and from LDL receptor-deficient mice (Lr–/–LDL), to induce foam cell formation.

Methods and Results— Binding studies using COS-7 cells overexpressing CD36, J774 cells, and mouse peritoneal macrophages (MPMs) unexpectedly showed for the first time that E–/–LDL, which is enriched in cholesterol, is a high-affinity ligand for CD36 and exhibited greater macrophage uptake than Lr–/–LDL or normal LDL. Minimal copper-mediated oxidization of Lr–/–LDL or C57LDL in vitro resulted in increased ligand internalization, although cell uptake of these oxidized LDLs was lower than that of E–/–LDL, even at oxidation levels similar to that found in E–/–LDL. Treatment of MPMs with E–/–LDL and Lr–/–LDL (to a 2- to 3-fold lesser extent), but not normal LDL, resulted in significant cellular cholesteryl ester accumulation and foam cell formation. Experiments using MPMs lacking CD36, scavenger receptor class A (SR-A), or both, indicated a major contribution of CD36 (50%), and to a lesser extent, SR-A (24% to 30%), to E–/–LDL uptake.

Conclusions— Because of its increased state of oxidation and high cholesterol content, LDL in apoE-deficient mice acts in a proatherogenic manner, without requiring further modification in the vascular wall, to induce foam cell formation through its uptake by scavenger receptors.

We investigated the atherogenic capability of circulating LDL from apoE-deficient mice and found that it functions in a proatherogenic manner, even without any further modification in vascular wall, through its uptake by scavenger receptors CD36 and SR-A.

Key Words: apolipoprotein E • macrophages • scavenger receptor • CD36 • SR-A

	Introduction

Top Abstract Introduction Methods Results Discussion References

 
On a chow diet, apolipoprotein E (apoE)-deficient (apoE–/–) mice have highly elevated plasma cholesterol levels attributable mainly to the accumulation of very-low-density lipoprotein (VLDL) remnants and develop severe atherosclerotic lesions spontaneously.^1,2 LDL receptor-deficient (LDLr–/–) mice, which have mildly increased plasma cholesterol levels from the accumulation of LDL on a chow diet, are also prone to atherosclerosis, but advanced lesions develop only on a high-fat, high-cholesterol diet.^3–5 Mechanisms by which these lipoprotein remnants induce macrophage foam cell formation and subsequent atherogenesis are uncertain.

Earlier studies have shown that VLDL, VLDL/intermediate-density lipoprotein (IDL), and the non-high-density lipoprotein (HDL) fraction from apoE–/– mice induce modest lipid accumulation in cultured macrophages and that modification of these lipoproteins stimulates further lipid uptake, evidently by receptors other than scavenger receptor class A (SR-A) or CD36.^6–9 However, a role for SR-A as well as CD36 in macrophage lipid accumulation has been demonstrated in vitro and in vivo. In vitro studies showed that SR-A and CD36 expression in macrophages accounts for 75% to 90% of degradation of LDL modified by acetylation or oxidation.¹⁰ Studies with SR-A- or CD36-deficient mice showed that disruption of either receptor in mice lacking apoE partially inhibits uptake of acetylated LDL or oxidized LDL (oxLDL) in macrophages and retards atherosclerotic progression.^11,12

To date, no studies have specifically investigated the capability of naturally occurring LDL from hyperlipidemic models (eg, mice lacking apoE) to induce foam cell formation. The study of LDL is potentially important because LDL from apoE–/– mice shows evidence of being oxidized to some extent in vivo.^13,14 Furthermore, compared with VLDL/IDL particles,^6–9 smaller LDL particles more readily enter the arterial wall and accumulate in the subendothelial space, where they may become modified and subsequently taken up by macrophages in an unregulated manner by scavenger receptors.^15,16 In this study, we investigated the abilities of LDL from apoE–/– mice, LDLr–/– mice, and C57BL/6 mice to induce foam cell formation. Our results surprisingly show that circulating E–/–LDL, and to a lesser extent, Lr–/–LDL, are actual ligands for scavenger receptors, particularly CD36, and induce significant macrophage cholesteryl ester (CE) accumulation.

	Methods

Top Abstract Introduction Methods Results Discussion References

 
Mice
ApoE–/–, LDLr–/–, and C57BL/6 mice were obtained from Jackson Laboratories. CD36–/– mice were kindly provided by R.L. Silverstein (Weill Medical College of Cornell University, New York, NY). SR-A–/– mice were kindly provided by M.F. Linton (Vanderbilt University Medical Center, Nashville, Tenn). CD36/SR-A double knockout mice were cross-bred in our laboratory. All of the mice were on a C57BL/6 background, aged 6- to 8-weeks old, and maintained in a pathogen-free facility under equal light/dark cycles with free access to water and food. All procedures were approved by the Veterans Administration Medical Center institutional animal use and care committee.

Cell Culture
COS-7 cells and J774 cells were grown in DMEM supplemented with 10% FBS and 1% penicillin and streptomycin (GIBCO/BRL). Mouse peritoneal macrophages (MPMs) were harvested 4 days after intraperitoneal injection of 1 mL 2% bio-gel beads by peritoneal lavage using ice-cold PBS. Cells were washed, counted, and seeded at 2.5x10⁶ cells/12-well plate in DMEM complete medium containing 10% heat-inactivated FCS and 1000 IU/mL recombinant human M-colony-stimulating factor (CSF). Adherent cells were washed after overnight incubation and used.

LDL Particle Isolation and Radiolabeling
ApoE–/–, LDLr–/–, and C57BL/6 mice (20 to 30 each) were fasted 6 hours before blood collection. To minimize oxidation, collected blood was immediately mixed with EDTA (final concentration 2 mmol/L) and cooled on ice. LDL (d=1.019 to 1.063 g/mL) was isolated rapidly by sequential ultracentrifugation using a VTi 90 rotor (Beckman Coulter) as described previously.¹⁷ The isolated LDLs were stored under N₂ gas at 4°C and were used immediately after preparation. Minimally oxidized mouse LDLs were prepared by dialysis against 150 mmol/L NaCl, pH 7.4, containing 5 µmol/L CuSO₄ at 4°C for 2, 4, or 8 hours. Oxidation was terminated by the addition of 10 µmol/L EDTA. Lipid peroxide (LPO) content of LDL formed during oxidation was measured by a modified iodometric method.¹⁸

Lipoproteins were iodinated by the iodine monochloride method.¹⁹ The range of specific activity of iodinated lipoproteins was 50 to 200 cpm/ng protein, and lipid iodination was <0.1% of iodination on protein. The integrity of all labeled lipoproteins was verified by SDS-PAGE and gradient gel electrophoresis. The electrophoretic mobility in nondenaturing agarose gels of E–/–LDL was similar to that of Lr–/–LDL. Lipid compositions were determined enzymatically (WAKO Chemicals). Protein was quantified by Lowry method.²⁰

Adenoviral Vectors Infection
CD36 adenovirus (AdCD36) was prepared as described previously.²¹ AdNull (provided by Dr D.J. Rader, University of Pennsylvania, Philadelphia) is a recombinant virus with analogous adenoviral sequences containing no transgene. COS-7 cells were seeded in 12-well plates 48 hours before assays (2.5x10⁵ cells per well). Overexpression was performed by addition of AdNull and AdCD36 at a viral dose of 1000 particles per cell 24 hours before assay. At this dose, 95% of cells expressed mCD36 as shown by indirect immunofluorescence. Western blotting for CD36 was performed as described previously.²¹

Ligand Binding and Uptake Assays
Cell association and degradation assays, described previously,²² were performed at 37°C in DMEM supplemented with 0.5% essentially fatty acid-free BSA, 1% penicillin and streptomycin, and radiolabeled lipoprotein. All values are shown in terms of LDL protein, which is associated or degraded by the cells. K_d and B_max values were determined by nonlinear regression analysis of receptor-specific values using Prism software (GraphPad Software).

Lipid Accumulation in MPM Cells Exposed to Lipoproteins
MPM cells were collected, seeded, and incubated for 1 day as described above and then incubated with different lipoproteins (150 µg/mL) in DMEM complete medium at 37°C for 2 days. To visualize lipid droplets by oil red O staining, cells were washed twice with PBS, fixed with 4% paraformaldehyde for 10 minutes, rinsed once quickly in 60% isopropyl alcohol, stained in 0.3% oil red O solution for 10 minutes, washed briefly in 60% isopropyl alcohol, and then mounted using 50% glycerol. To determine CE accumulation, lipids were extracted by incubation for 30 minutes with 2 mL hexane/isopropanol (3:2 by volume), dried under nitrogen gas, dissolved in chloroform with 0.5% Triton X-100, dried again under nitrogen gas, and then resuspended in 0.225 mL water by vortex and incubation at 37°C for 15 minutes. Aliquots of lipid extract were used for determination of total cholesterol and unesterified cholesterol by enzymatic kits (WAKO Chemicals).

Statistics
Data were expressed as mean±SD. Results were analyzed by Student t test. A value of P<0.05 was considered significant.

	Results

Top Abstract Introduction Methods Results Discussion References

 
Distinct Lipid and Apolipoprotein Composition of E–/–LDL, Lr–/–LDL, and C57LDL
The lipid composition of LDL particles from 3 types of mice, namely apoE–/–, LDLr–/–, and C57BL/6 mice, differed significantly in composition, the greatest difference being between E–/–LDL and C57LDL (Table). Protein and triglyceride mass percentage values increased in the order of E–/–LDL to Lr–/–LDL to C57LDL, whereas cholesterol (free and esterified cholesterol) and phospholipids decreased in the same order. E–/–LDL is therefore relatively enriched in total and free cholesterol. LDLs also differ in their apolipoprotein composition (Figure I, available online at http://atvb.ahajournals.org). E–/–LDL contains apoB-48 as the major apolipoprotein, as well as significant amounts of apoB-100, apoA-IV, and apoA-I. Lr–/–LDL and C57LDL each contain apoB-100 as the major apoB species, together with apoB-48, apoE, and apoA-I in Lr–/–LDL and apoE and apoA-I in C57LDL. Small amounts of apoA-II and C peptides are found in each of the LDLs.

View this table: [in this window] [in a new window]   Lipid Composition of Mouse LDL Particles

CD36 Binds and Internalizes E–/–LDL
COS-7 cells expressed CD36 through adenovirus-mediated gene transfer at a comparable level to that found in the macrophage cell line, J774 (Figure 1A). E–/–LDL and Lr–/–LDL exhibited saturable high-affinity association to CD36, and association of Lr–/–LDL was 4-fold lower than E–/–LDL (Figure 1B). Significant degradation of E–/–LDL was observed, whereas degradation of Lr–/–LDLwas markedly lower (10- to 15-fold) than that of E–/–LDL (Figure 1C). These data indicate that E–/–LDL is a high-affinity ligand for CD36 and is efficiently internalized by the receptor.

View larger version (21K): [in this window] [in a new window]   Figure 1. CD36-expressing COS-7 cell association and degradation of E–/–LDL and Lr–/–LDL. COS-7 cells were treated with AdCD36 or control AdNull virus for 24 hours as described in Methods. A, Immunoblot for CD36 (10-µg cell protein per lane). Lanes 1 and 2, AdCD36-treated cells; lanes 3 and 4, AdNull-treated cells; lanes 5 and 6, J774 cells. Concentration-dependent cell association (B) or degradation (C) of 125I-E–/–LDL and 125I-Lr–/–LDL at 37°C for 2 hours was quantified as described in Methods. Shown are CD36-specific values, which were calculated as the difference between AdCD36-treated cells and AdNull-treated cells. Apparent association Kd values for E–/–LDL and Lr–/–LDL were 16±2 and 23±5 µg/mL; and Bmax values were 1667±60 and 447±45 ng ligand/mg cell protein, respectively.

Macrophages Bind and Take Up E–/–LDL and Lr–/–LDL in a CD36 and SR-A-Dependent Manner
E–/–LDL and Lr–/–LDL associated with J774 cells at 37°C in a high-affinity saturable manner with an 2-fold greater association of E–/–LDL than Lr–/–LDL (Figure 2A). A more marked difference between 2 LDLs was seen in ligand degradation that was 5-fold higher for E–/–LDL than Lr–/–LDL (Figure 2B). The greater difference in degradation of the 2 LDLs, compared with the difference in their cell association, suggests a lower efficiency of internalization of Lr–/–LDL compared with E–/–LDL, or that Lr–/–LDL is internalized but is more resistant to degradation, or that some Lr–/–LDL is bound to surface sites that do not mediate internalization.

View larger version (22K): [in this window] [in a new window]   Figure 2. J774 cell association and degradation of E–/–LDL and Lr–/–LDL. J774 cells were incubated with 125I-E–/–LDL and 125I-Lr–/–LDL at 37°C for 2 hours at the indicated concentration. Cell association (A) and degradation (B) were quantified as described in Methods. Apparent association Kd values for E–/–LDL were 4.4±0.7 and 6.4±1.0 µg/mL, respectively; and Bmax values were 1121±50 and 653±32 ng protein/mg cell protein, respectively.

As observed in J774 cells, E–/–LDL exhibited significantly greater degradation (2.5-fold) than Lr–/–LDL in MPMs from normal mice (Figure 3A). Degradation was significantly reduced (50%) for E–/–LDL, to a lesser extent (24% reduction) for Lr–/–LDL, in MPMs lacking CD36. Decreased ligand degradation was also observed in SR-A–/– cells (Figure 3B). The SR-A dependent contribution was similar for E–/–LDL (30%) and Lr–/–LDL (25%). In MPMs lacking CD36 and SR-A, degradation of E–/–LDL or Lr–/–LDL was further decreased, resulting in similar degradation values for 2 ligands. Cell association values showed similar trends as those seen with ligand degradation (data not shown). These results indicate that CD36 and SR-A are responsible for the difference in macrophage uptake of the 2 ligands, and that CD36 contributes more to the uptake of E–/–LDL than SR-A.

View larger version (21K): [in this window] [in a new window]   Figure 3. Cellular degradation of E–/–LDL and Lr–/–LDL in MPM cells. MPMs were collected and seeded as described in Methods and then incubated for 5 hours at 37°C with 125I-E–/–LDL or 125I-Lr–/–LDL, each at the concentration 10 µg/mL. Cell degradation in C57 and CD36–/– MPMs (A), and in C57, SR-A–/–, and CD36/SR-A double knockout MPMs (B) were determined as described in Methods. +P<0.05 vs C57; *P<0.05 vs E–/–LDL.

Effect of Oxidation on LDL Uptake and Degradation
We next assessed the extent to which lipoprotein oxidation might contribute to the enhanced uptake of E–/–LDL. LPO content in freshly isolated E–/–LDL was 2.5-fold higher than that in Lr–/–LDL or C57LDL (Figure 4). Oxidation over short periods in vitro increased LPO content in Lr–/–LDL and C57LDL. CD36-dependent degradation in COS-7 cells of minimally oxidized Lr–/–LDLs or C57LDLs was increased with increasing degree of oxidation. A similar increase in degradation of Lr–/–LDL with increasing levels of ligand oxidation was also observed in MPMs from C57BL/6J mice (data not shown). Despite the increased degradation observed with increased ligand oxidation, degradation of 4-hour and even 8-hour oxidized Lr–/–LDL or C57LDL was lower than that of E–/–LDL, although these ligands had levels of oxidation similar to E–/–LDL. Values for ligand cell association showed similar trends to those observed for degradation (data not shown). These results indicate that an increased level of oxidation of E–/–LDL might account, at least in part, for its greater uptake and degradation.

View larger version (25K): [in this window] [in a new window]   Figure 4. Cellular degradation of oxidized mouse LDLs. LDLs were oxidized for the indicated times as described in Methods. LPO content of LDLs is expressed as nmol/mg protein. CD36-specific degradation of native and oxLDL ligands (E–/–LDL, Lr–/–LDL, and C57LDL) was quantified as in Figure 2. +P<0.05 vs oxidized Lr–/–LDL (4 hours and 8 hours); *P<0.05 vs E–/–LDL; P<0.05 vs oxidized C57LDL (4 hours and 8 hours).

E–/–LDL Induces Foam Cell Formation in a CD36- and SR-A-Dependent Manner
E–/–LDL exposure induced significant lipid droplet formation in macrophages, and Lr–/–LDL induced fewer lipid droplets and C57LDL none (Figure 5A). Lipid droplets after exposure to E–/–LDL were distinctly reduced in CD36–/– MPMs, and further reduced but still seen in CD36/SR-A double knockout macrophages.

View larger version (48K): [in this window] [in a new window]   Figure 5. Macrophage foam cell formation induced by E–/–LDL and Lr–/–LDL. MPMs from C57, CD36–/–, and CD36/SR-A double knockout mice were collected and incubated at 37°C for 2 days in complete DMEM media (with 10% FBS and 1000 IU/mL M-CSF) containing E–/–LDL, Lr–/–LDL, or C57LDL at a concentration of 150 µg/mL. A, Cells stained with oil red O. Higher (x60) magnification images in C57 macrophages are shown in the top row. B, Lipids were extracted and measured as described in Methods. CE mass is expressed relative to that in E–/–LDL-treated C57 cells, which was 48.3±16.6 µg CE/mg cell protein. +P<0.05 vs C57; *P<0.05 vs E–/–LDL.

E–/–LDL treatment caused significant cellular CE accumulation in C57 MPMs to levels 2-fold greater than with Lr–/–LDL, whereas C57LDL led to negligible CE accumulation (Figure 5B). CE accumulation induced by E–/–LDL or Lr–/–LDL was significantly reduced in MPMs lacking CD36 or SR-A, and further reduced in cells lacking the 2 receptors. In CD36–/– cells, the reduction of CE accumulation was greater for E–/–LDL (50%) and less for Lr–/–LDL (20%). These results show that E–/–LDL, and to a lesser extent, Lr–/–LDL, increase more foam cell formation in a CD36- and SR-A-dependent manner.

	Discussion

Top Abstract Introduction Methods Results Discussion References

 
The marked difference observed in MPMs between binding and internalization of E–/–LDL and Lr–/–LDL was also shown in macrophage cell line J774 that expresses CD36 and SR-A. These cells do not express apoE,²³ indicating that E–/–LDL internalization occurred by an apoE-independent mechanism. This was confirmed by enhanced uptake of E–/–LDL in MPMs from apoE–/– mice (data not shown). Unlike Lr–/–LDL, E–/–LDL contains apoB-48 as the major apolipoprotein and very small amounts of apoB-100.²⁴ Together, these results demonstrate that uptake of E–/–LDL was not dependent on LDL receptor or a related receptor, such as LRP, that recognizes either apoB-100 or apoE as ligands. The pathway by which CD36 mediates the internalization of lipoprotein ligands such as oxLDL is still poorly defined.²⁵ It was reported recently that CD36-mediated endocytosis of oxLDL uses lipid rafts in a pathway that does not require caveolin-1 or clathrin.²⁶ Our results in J774 cells similarly indicate the uptake of E–/–LDL via a caveolin-1-independent pathway because J774 cells lack caveolin-1.²⁷

Previous studies of apoB-containing lipoproteins from apoE–/– mice showed induction of foam cell formation, and the identity of the receptor(s) responsible for lipid uptake in those studies is not known.^6–9 The present study shows for the first time that E–/–LDL, unlike Lr–/–LDL, is a circulating lipoprotein fraction that is an efficient ligand for CD36. One explanation for this is a greater degree oxidation in E–/–LDL. Studies have documented previously that E–/–LDL is oxidized in vivo, for example, autoantibodies to oxLDL epitopes are found in apoE–/– mouse plasma,^13,14 and E–/–LDL shows increased lipid peroxidation.^28,29 As shown in this study, freshly isolated E–/–LDL has a 2.5-fold higher LPO content than Lr–/–LDL or C57LDL, probably the result of the different degrees of hypercholesterolemia in these mice. CD36, unlike SR-A, has a preference for less or "minimal" oxLDL.^25,30 CD36 can mediate uptake of modified lipoprotein particles through an interaction with the oxidized lipid moiety,³¹ which can be in the lipid phase or covalently attached to apoB.^31,32 For this reason, CD36, rather than SR-A, may be the preferred receptor for E–/–LDL that has undergone minimal oxidation. This is supported by our experiments using minimally oxidized Lr–/–LDL or C57LDL, which indicate that minimal ligand oxidation might contribute to the greater ligand activity of E–/–LDL.

Another modification that E–/–LDL undergoes in vivo is aggregation,^33,34 a process that is enhanced by E–/–LDL oxidation³⁴ as well as by sphingomyelin hydrolysis.^9,35,36 Uptake of aggregated lipoproteins could occur through the process of patocytosis.^37,38 Although we cannot rule out an effect of ligand aggregation in our experiments, filtering the E–/–LDL ligand using a 0.22-µm filter to remove any larger aggregates immediately before incubation with macrophages had no effect on foam cell formation (data not shown). We conclude that the greater efficiency of E–/–LDL uptake by scavenger receptors, together with the greater content of cholesterol carried in each E–/–LDL particle, account for the greater macrophage lipid accumulation caused by E–/–LDL compared with Lr–/–LDL or control LDL.

A modest level of E–/–LDL uptake and CE accumulation occurs even in MPMs lacking CD36 and SR-A, indicating the possible involvement of another receptor(s). These candidates include other scavenger receptors that interact with modified lipoproteins.³⁹ We showed previously that scavenger receptor BI, an HDL receptor, did not mediate the uptake of apoB-containing lipoproteins from apoE–/– mice, despite high-affinity, high-capacity binding.²⁴ Macrosialin, a type D scavenger receptor, has been shown by ligand blotting to bind oxLDL.^40–42 However, we reported recently that this receptor, which is predominantly an intracellular protein, does not bind oxLDL at macrophage cell surface, and is therefore unlikely to mediate E–/–LDL-induced lipid accumulation.¹⁷ Other candidates include lectin-like oxLDL receptor 1, a macrophage receptor containing a collagenous domain, and endothelial cell scavenger receptor. Such pathways are unlikely to contribute to Lr–/–LDL uptake because there was negligible CE accumulation induced by this ligand in CD36/SR-A double knockout macrophages.

In summary, we show for the first time that a circulating plasma LDL fraction namely, LDL from apoE–/– mice, functions as an efficient ligand for CD36 without requiring further modification and promotes macrophages foam cell formation. Enhanced uptake of E–/–LDL by scavenger receptors, particularly CD36, may contribute to the spontaneous development of atherosclerosis in apoE-deficient mice.

	Acknowledgments

 
This work was supported in part by National Institutes of Health Grants AA-00292 (W.J.S.d.), HL-65730 and HL-63763 (D.R.v.). The authors thank Xin Shi, Wei Shi, Jason Cupp, and Nathan Whitaker for excellent technical assistance, and Nancy R. Webb for critical review of this manuscript.

Received August 4, 2004; accepted October 14, 2004.

	References

Top Abstract Introduction Methods Results Discussion References

 
1. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb. 1994; 14: 133–140.[Abstract/Free Full Text]

2. Reddick RL, Zhang SH, Maeda N. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler Thromb. 1994; 14: 141–147.[Abstract/Free Full Text]

3. Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest. 1993; 92: 883–893.

4. Veniant MM, Withycombe S, Young SG. Lipoprotein size and atherosclerosis susceptibility in Apoe(–/–) and Ldlr(–/–) mice. Arterioscler Thromb Vasc Biol. 2001; 21: 1567–1570.[Abstract/Free Full Text]

5. Daugherty A. Mouse models of atherosclerosis. Am J Med Sci. 2002; 323: 3–10.[CrossRef][Medline] [Order article via Infotrieve]

6. Hendriks WL, van der Sman-de Beer F, van Vlijmen BJ, van Vark LC, Hofker MH, Havekes LM. Uptake by J774 macrophages of very-low-density lipoproteins isolated from apoE-deficient mice is mediated by a distinct receptor and stimulated by lipoprotein lipase. Arterioscler Thromb Vasc Biol. 1997; 17: 498–504.[Abstract/Free Full Text]

7. Whitman SC, Hazen SL, Miller DB, Hegele RA, Heinecke JW, Huff MW. Modification of type III VLDL, their remnants, and VLDL from ApoE-knockout mice by p-hydroxyphenylacetaldehyde, a product of myeloperoxidase activity, causes marked cholesteryl ester accumulation in macrophages. Arterioscler Thromb Vasc Biol. 1999; 19: 1238–1249.[Abstract/Free Full Text]

8. Hakamata H, Sakaguchi H, Zhang C, Sakashita N, Suzuki H, Miyazaki A, Takeya M, Takahashi K, Kitamura N, Horiuchi S. The very low- and intermediate-density lipoprotein fraction isolated from apolipoprotein E-knockout mice transforms macrophages to foam cells through an apolipoprotein E-independent pathway. Biochemistry. 1998; 37: 13720–13727.[CrossRef][Medline] [Order article via Infotrieve]

9. Marathe S, Choi Y, Leventhal AR, Tabas I. Sphingomyelinase converts lipoproteins from apolipoprotein E knockout mice into potent inducers of macrophage foam cell formation. Arterioscler Thromb Vasc Biol. 2000; 20: 2607–2613.[Abstract/Free Full Text]

10. Kunjathoor VV, Febbraio M, Podrez EA, Moore KJ, Andersson L, Koehn S, Rhee JS, Silverstein R, Hoff HF, Freeman MW. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J Biol Chem. 2002; 277: 49982–49988.[Abstract/Free Full Text]

11. Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, Jishage K, Ueda O, Sakaguchi H, Higashi T, Suzuki T, Takashima Y, Kawabe Y, Cynshi O, Wada Y, Honda M, Kurihara H, Aburatani H, Doi T, Matsumoto A, Azuma S, Noda T, Toyoda Y, Itakura H, Yazaki Y, Kodama T. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature. 1997; 386: 292–296.[CrossRef][Medline] [Order article via Infotrieve]

12. Febbraio M, Podrez EA, Smith JD, Hajjar DP, Hazen SL, Hoff HF, Sharma K, Silverstein RL. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest. 2000; 105: 1049–1056.[Medline] [Order article via Infotrieve]

13. Palinski W, Ord VA, Plump AS, Breslow JL, Steinberg D, Witztum JL. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler Thromb. 1994; 14: 605–616.[Abstract/Free Full Text]

14. Palinski W, Horkko S, Miller E, Steinbrecher UP, Powell HC, Curtiss LK, Witztum JL. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest. 1996; 98: 800–814.[Medline] [Order article via Infotrieve]

15. Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol. 1995; 15: 551–561.[Free Full Text]

16. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM. PPAR promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell. 1998; 93: 241–252.[CrossRef][Medline] [Order article via Infotrieve]

17. de Beer MC, Zhao Z, Webb NR, Van Der Westhuyzen DR, De Villiers WJ. Lack of a direct role for macrosialin in oxidized LDL metabolism. J Lipid Res. 2003; 44: 674–685.[Abstract/Free Full Text]

18. el-Saadani M, Esterbauer H, el-Sayed M, Goher M, Nassar AY, Jurgens G. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res. 1989; 30: 627–630.[Abstract]

19. Bilheimer DW, Eisenberg S, Levy RI. The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. Biochim Biophys Acta. 1972; 260: 212–221.[Medline] [Order article via Infotrieve]

20. Lowry OH, Rosebrought NJ, Farr AL, Randall BJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951; 193: 265–275.[Free Full Text]

21. de Villiers WJ, Cai L, Webb NR, de Beer MC, van der Westhuyzen DR, de Beer FC. CD36 does not play a direct role in HDL or LDL metabolism. J Lipid Res. 2001; 42: 1231–1238.[Abstract/Free Full Text]

22. Webb NR, Connell PM, Graf GA, Smart EJ, de Villiers WJ, de Beer FC, van der Westhuyzen DR. SR-BII, an isoform of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells. J Biol Chem. 1998; 273: 15241–15248.[Abstract/Free Full Text]

23. Werb Z, Chin JR. Onset of apoprotein E secretion during differentiation of mouse bone marrow-derived mononuclear phagocytes. J Cell Biol. 1983; 97: 1113–1118.[Abstract/Free Full Text]

24. Webb NR, de Beer MC, de Beer FC, van der Westhuyzen DR. ApoB-containing lipoproteins in apoE-deficient mice are not metabolized by the class B scavenger receptor BI. J Lipid Res. 2004; 45: 272–280.[Abstract/Free Full Text]

25. Febbraio M, Hajjar DP, Silverstein RL. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest. 2001; 108: 785–791.[CrossRef][Medline] [Order article via Infotrieve]

26. Zeng Y, Tao N, Chung KN, Heuser JE, Lublin DM. Endocytosis of oxidized low density lipoprotein through scavenger receptor CD36 utilizes a lipid raft pathway that does not require caveolin-1. J Biol Chem. 2003; 278: 45931–45936.[Abstract/Free Full Text]

27. Gargalovic P, Dory L. Caveolin-1 and caveolin-2 expression in mouse macrophages. High density lipoprotein 3-stimulated secretion and a lack of significant subcellular co-localization. J Biol Chem. 2001; 276: 26164–26170.[Abstract/Free Full Text]

28. Cyrus T, Pratico D, Zhao L, Witztum JL, Rader DJ, Rokach J, FitzGerald GA, Funk CD. Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein E-deficient mice. Circulation. 2001; 103: 2277–2282.[Abstract/Free Full Text]

29. Fuhrman B, Aviram M. Preservation of paraoxonase activity by wine flavonoids: possible role in protection of LDL from lipid peroxidation. Ann N Y Acad Sci. 2002; 957: 321–324.[Medline] [Order article via Infotrieve]

30. Podrez EA, Schmitt D, Hoff HF, Hazen SL. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J Clin Invest. 1999; 103: 1547–1560.[Medline] [Order article via Infotrieve]

31. Boullier A, Gillotte KL, Horkko S, Green SR, Friedman P, Dennis EA, Witztum JL, Steinberg D, Quehenberger O. The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein. J Biol Chem. 2000; 275: 9163–9169.[Abstract/Free Full Text]

32. Podrez EA, Poliakov E, Shen Z, Zhang R, Deng Y, Sun M, Finton PJ, Shan L, Febbraio M, Hajjar DP, Silverstein RL, Hoff HF, Salomon RG, Hazen SL. A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions. J Biol Chem. 2002; 277: 38517–38523.[Abstract/Free Full Text]

33. Aviram M, Maor I, Keidar S, Hayek T, Oiknine J, Bar-El Y, Adler Z, Kertzman V, Milo S. Lesioned low density lipoprotein in atherosclerotic apolipoprotein E-deficient transgenic mice and in humans is oxidized and aggregated. Biochem Biophys Res Commun. 1995; 216: 501–513.[CrossRef][Medline] [Order article via Infotrieve]

34. Maor I, Hayek T, Coleman R, Aviram M. Plasma LDL oxidation leads to its aggregation in the atherosclerotic apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 1997; 17: 2995–3005.[Abstract/Free Full Text]

35. Schissel SL, Jiang X, Tweedie-Hardman J, Jeong T, Camejo EH, Najib J, Rapp JH, Williams KJ, Tabas I. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development. J Biol Chem. 1998; 273: 2738–2746.[Abstract/Free Full Text]

36. Jeong T, Schissel SL, Tabas I, Pownall HJ, Tall AR, Jiang X. Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase. J Clin Invest. 1998; 101: 905–912.[Medline] [Order article via Infotrieve]

37. Huang W, Ishii I, Zhang WY, Sonobe M, Kruth HS. PMA activation of macrophages alters macrophage metabolism of aggregated LDL. J Lipid Res. 2002; 43: 1275–1282.[Abstract/Free Full Text]

38. Kruth HS. Sequestration of aggregated low-density lipoproteins by macrophages. Curr Opin Lipidol. 2002; 13: 483–488.[CrossRef][Medline] [Order article via Infotrieve]

39. de Villiers WJ, Smart EJ. Macrophage scavenger receptors and foam cell formation. J Leukoc Biol. 1999; 66: 740–746.[Abstract]

40. Van Velzen AG, Da Silva RP, Gordon S, Van Berkel TJ. Characterization of a receptor for oxidized low-density lipoproteins on rat Kupffer cells: similarity to macrosialin. Biochem J. 1997; 322: 411–415.

41. Ramprasad MP, Terpstra V, Kondratenko N, Quehenberger O, Steinberg D. Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc Natl Acad Sci U S A. 1996; 93: 14833–14838.[Abstract/Free Full Text]

42. Ramprasad MP, Fischer W, Witztum JL, Sambrano GR, Quehenberger O, Steinberg D. The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc Natl Acad Sci U S A. 1995; 92: 9580–9584.[Abstract/Free Full Text]

This article has been cited by other articles:

				D. J. Kennedy, S. D. Kuchibhotla, E. Guy, Y. M. Park, G. Nimako, D. Vanegas, R. E. Morton, and M. Febbraio Dietary Cholesterol Plays a Role in CD36-Mediated Atherogenesis in LDLR-Knockout Mice Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1481 - 1487. [Abstract] [Full Text] [PDF]

				B. Boyanovsky, M. Zack, K. Forrest, and N. R. Webb The Capacity of Group V sPLA2 to Increase Atherogenicity of ApoE-/- and LDLR-/- Mouse LDL In Vitro Predicts its Atherogenic Role In Vivo Arterioscler Thromb Vasc Biol, April 1, 2009; 29(4): 532 - 538. [Abstract] [Full Text] [PDF]

				S. Kuchibhotla, D. Vanegas, D. J. Kennedy, E. Guy, G. Nimako, R. E. Morton, and M. Febbraio Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II Cardiovasc Res, April 1, 2008; 78(1): 185 - 196. [Abstract] [Full Text] [PDF]

				D. Wu, C. Sharan, H. Yang, J. S. Goodwin, L. Zhou, G. A. Grabowski, H. Du, and Z. Guo Apolipoprotein E-deficient lipoproteins induce foam cell formation by downregulation of lysosomal hydrolases in macrophages J. Lipid Res., December 1, 2007; 48(12): 2571 - 2578. [Abstract] [Full Text] [PDF]

				Y.-L. Lin, W. J. S. de Villiers, B. Garvy, S. R. Post, T. R. Nagy, F. F. Safadi, M. C. Faugere, G. Wang, H. H. Malluche, and J. P. Williams The Effect of Class A Scavenger Receptor Deficiency in Bone J. Biol. Chem., February 16, 2007; 282(7): 4653 - 4660. [Abstract] [Full Text] [PDF]

				A. Handberg, K. Levin, K. Hojlund, and H. Beck-Nielsen Identification of the Oxidized Low-Density Lipoprotein Scavenger Receptor CD36 in Plasma: A Novel Marker of Insulin Resistance Circulation, September 12, 2006; 114(11): 1169 - 1176. [Abstract] [Full Text] [PDF]

				C. A. Beamer and A. Holian Scavenger receptor class A type I/II (CD204) null mice fail to develop fibrosis following silica exposure Am J Physiol Lung Cell Mol Physiol, August 1, 2005; 289(2): L186 - L195. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Data Supplement All Versions of this Article: 25/1/168    most recent 01.ATV.0000149145.00865.d9v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhao, Z. Articles by van der Westhuyzen, D. R. Search for Related Content PubMed PubMed Citation Articles by Zhao, Z. Articles by van der Westhuyzen, D. R.